Literature DB >> 6947236

Selective natural killer resistance in a clone of YAC lymphoma cells.

J C Roder, T J Beaumont, R S Kerbel, T Haliotis, D Kozbor.   

Abstract

YAC lymphoma cells were treated with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine and then cloned and subcloned. Of 51 clones, 3 were selected for further study. Ten-fold more natural killer (NK) effector cells were required to lyse YAC clone 6 and subclone 6-28 cells compared with clone 19 cells or the YAC parent cell line. The maximum plateau level of cytolysis of the NK-resistant (NKR) variants (20%) never approached that of the NK-sensitive (NKS) variants or YAC parental cells (60%) even after prolonged incubation (20 hr). NKR variants appeared with equal frequency (0.10) on cloning YAC cells that had not been treated with mutagen but these variants were highly unstable with respect to NK sensitivity and were not studied further. Cytolysis of both NKR and NKS lines was mediated by nylon-nonadherent asialo-GM1+ effector cells, and effectors from poly(I) . poly(C)-boosted mice preferentially lysed the NKS lines. The NKR alteration did not appear to change the NK target structure (NK-TS): (i) unlabeled NKR cells competed equally with NKS cells in reciprocal unlabeled-target competition assays; (ii) the frequency of target--effector conjugates was identical with NKR or NKS lines; and (iii) normal rabbit serum, which contains antibodies thought to react with the NK-TS, reacted equally against both NKR and NKS targets. The NKR alteration was selective for NK cells and did not result in a resistance to lysis in general; NKR and NKS variants were equally susceptible to (i) cytolysis mediated by alloimmune or lectin-dependent effector T cells and (ii) antibody- and complement-mediated lysis. These results are compatible with the hypothesis that the NKR variants have an altered acceptor site on the target cell membrane that normally binds the "lytic moiety" delivered by the effector cell.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6947236      PMCID: PMC349046          DOI: 10.1073/pnas.78.10.6396

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Physico-chemical characteristics of tumour cells susceptible to lysis by natural killer (NK) cells.

Authors:  S Becker; O Stendahl; K E Magnusson
Journal:  Immunol Commun       Date:  1979

2.  Target-effector interaction in the natural killer cell system: isolation of target structures.

Authors:  J C Roder; A Rosén; E M Fenyö; F A Troy
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

4.  Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse.

Authors:  J C Roder; R Kiessling
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

5.  Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing.

Authors:  J C Roder; R Kiessling; P Biberfeld; B Andersson
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

6.  Immunologic studies of membrane mutants of a highly metastatic murine tumor.

Authors:  R S Kerbel
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

7.  "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.

Authors:  R Kiessling; E Klein; H Pross; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

8.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Tumorigenicity and lysis by natural killers.

Authors:  J L Collins; P Q Patek; M Cohn
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

10.  Target-effector interaction in the human and murine natural killer system: specificity and xenogeneic reactivity of the solubilized natural killer-target structure complex and its loss in a somatic cell hybrid.

Authors:  J C Roder; L Ahrlund-Richter; M Jondal
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more
  7 in total

Review 1.  Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.

Authors:  A E Lagarde
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 2.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

3.  YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.

Authors:  S C Wright; B Bonavida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

Review 4.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

5.  Studies on natural, antibody-dependent, and interleukin-2-activated killer-cell activity of a patient with mucolipidosis III as a test of the mannose-6-phosphate lytic acceptor hypothesis.

Authors:  J A Werkmeister; H F Pross
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

6.  Isolation and characterization of a low metastatic variant from EL-4 mouse T-lymphoma.

Authors:  T Ota; M Tanino; H Kohno; H Funamoto; S Odashima
Journal:  Clin Exp Metastasis       Date:  1992-09       Impact factor: 5.150

7.  Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR.

Authors:  Sarah E Gill; Qing Zhang; Gary L Keeney; William A Cliby; S John Weroha
Journal:  Oncotarget       Date:  2017-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.